Angiotensin-converting enzyme inhibitors: pathogenic and therapeutic implications for arterial hypertension.
作者信息
Waeber B, Brunner H R, Wauters J P, Gavras H
出版信息
Adv Nephrol Necker Hosp. 1981;10:111-33.
PMID:6267906
Abstract
摘要
相似文献
1
Angiotensin-converting enzyme inhibitors: pathogenic and therapeutic implications for arterial hypertension.
Adv Nephrol Necker Hosp. 1981;10:111-33.
2
[Angiotensin converting enzyme inhibitors--a new group of hypotensive drugs].
Wiad Lek. 1984 May 15;37(10):792-6.
3
Angiotensin inhibitors for hypertension.用于治疗高血压的血管紧张素抑制剂
Compr Ther. 1980 May;6(5):14-8.
4
[Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].卡托普利抑制转化酶对原发性高血压患者动脉血压、肾素及醛固酮的影响
Arch Inst Cardiol Mex. 1982 Jul-Aug;52(4):295-300.
5
[A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II].
Ned Tijdschr Geneeskd. 1980 Nov 22;124(47):1996-2003.
6
7
Angiotensin-converting enzyme inhibitors.血管紧张素转换酶抑制剂
Am Fam Physician. 1980 Nov;22(5):164-5.
8
[Renin-angiotensin system blocking drugs in the diagnosis and treatment of arterial hypertension].
Kardiol Pol. 1984;27(2):147-57.
9
10
Overview of the role of angiotensin inhibitors in delineating the function of the renin-angiotensin system.血管紧张素抑制剂在阐明肾素-血管紧张素系统功能中的作用概述。
Prog Biochem Pharmacol. 1980;17:29-35.
Zotero 插件